The Australian company Mesoblast begins clinical trials of angiogenesis stimulation technology in the heart by introducing

D. Likhachev

doi:10.23868/gc217684

Genes & Cells ›› 2006, Vol. 1 ›› Issue (2) : 27 -27. DOI: 10.23868/gc217684

Cell technology

research-article

The Australian company Mesoblast begins clinical trials of angiogenesis stimulation technology in the heart by introducing "adult" bone marrow stem cells

D. Likhachev

Author information +

History +

PDF

Abstract

Cite this article

Download citation ▾

D. Likhachev. The Australian company Mesoblast begins clinical trials of angiogenesis stimulation technology in the heart by introducing "adult" bone marrow stem cells. Genes & Cells, 2006, 1(2): 27-27 DOI:10.23868/gc217684